Newsfeeds - Spark Newswire

2 minute read

News

Anavex Life Sciences Announces ANAVEX2-73 Improved both Primary Cognitive and Secondary MDS-UPDRS Efficacy Endpoints with Significant Biomarker Correlation in Placebo-Controlled Phase 2 Clinical Trial for the Treatment of Patients with Par

Today, 8:23 AM

ANAVEX®2-73 treatment resulted in significant increase in the expression of the SIGMAR1 mRNA biomarker that significantly correlated with improvements in the primary and secondary clinical efficacy endpoints CoA (p =

AVXL

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 8:23 AM

APVO

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 8:23 AM

ADIL

5 minute read

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal

By Shanthi Rexaline

Today, 8:23 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)

ABCL

4 minute read

48 Biggest Movers From Yesterday

By Lisa Levin

Today, 8:23 AM

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.

AEI

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 8:23 AM

APVO

3 minute read

31 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 8:23 AM

Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.

AEI

1 minute read

Anavex Life’s Rett Syndrome Candidate Shows Promising Biomarker Correlating Efficacy Data

By Vandana Singh

Today, 8:23 AM

Anavex Life Sciences Corp (NASDAQ:AVXL) has reported a predictive biomarker response from its Phase 2 trial of ANAVEX2-73 (blarcamesine) in…

AVXL

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 8:23 AM

AHCO

4 minute read

News

Anavex Life Sciences Announces ANAVEX®2-73 Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome

By Benzinga Newsdesk

Today, 8:23 AM

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and

AVXL